ArticleCancer immunology, immunotherapy : CII2021

Anti-tumor effects of RTX-240: an engineered red blood cell expressing 4-1BB ligand and interleukin-15.

Shannon L McArdel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.